Who Owns SAGE?

The UK’s government’s Scientific Advisory Group for Emergencies (SAGE) was established in 2020 to “provide scientific and technical advice to support government decision makers during emergencies”. The latest of these has been the COVID-19 pandemic. SAGE members are drawn from a spectrum of disciplines including epidemiology, immunology, pharmaceutics, public health, psychology, modelling and statistics. BeginningContinue reading “Who Owns SAGE?”

Fear of COVID-19

COVID-19 Milestone Series In previous posts, here and here, I have drawn attention to the role of functional fear in human responses to COVID-19 pandemic. For various imaginable reasons, the government’s policy advisors do not openly discuss the use of fear in public health interventions, yet it is obvious to any observer that increasing fearContinue reading “Fear of COVID-19”

The Fear Motive – Missing from the Model

Capability, opportunity, and motivation to enact hygienic practices in the early stages of theCOVID-19 outbreak in the United Kingdom COVID-19 Milestone Series Extract from the originally published article in the British Journal of Health Psychology (2020), 25, 856–864. Authors: Jilly Gibson Miller et al. Open Access. This is an open access article under the termsContinue reading “The Fear Motive – Missing from the Model”

Omicron

Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear COVID-19 Milestone Series Originally published by the BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2943 (Published 29 November 2021) Cite this as: BMJ 2021;375:n2943 Author: Ingrid Torjesen Omicron, the SARS-CoV-2 variant responsible for a cluster of cases in South Africa and that is now spreading around the world,Continue reading “Omicron”

Pfizer’s Vaccine Trial Questioned

COVID-19 Milestone Series Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial Originally published in the BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2635 on 02 November 2021 by Paul D Thacker, investigative journalist This post republishes an article about “Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raiseContinue reading “Pfizer’s Vaccine Trial Questioned”